Celecoxib augmentation of continuously Ill patients with schizophrenia

Biological Psychiatry

Volumn 57, Issue 12, 2005, Pages 1594-1596

  Rapaport, Mark Hyman ^a,b   Delrahim, Katia K ^c   Bresee, Catherine J ^a   Maddux, Rachel E ^f   Ahmadpour, Oliver ^d   Dolnak, Douglas ^e  

^a CEDARS SINAI MEDICAL CENTER   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c PEPPERDINE UNIVERSITY   (United States)

^d UNIVERSITY OF SOUTHERN CALIFORNIA   (United States)

^e CALIFORNIA CLINICAL TRIALS   (United States)

^f GEORGIA STATE UNIVERSITY   (United States)

Author keywords

Augmentation strategies; Celecoxib; Cyclooxygenase 2 inhibitor; Psychoimmunology; Psychopathology; Schizophrenia

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIHYPERTENSIVE AGENT; CELECOXIB; OLANZAPINE; ORAL ANTIDIABETIC AGENT; PLACEBO; RISPERIDONE;

ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DOUBLE BLIND PROCEDURE; DRUG DOSE REGIMEN; DRUG EFFECT; DRUG POTENTIATION; EXTRAPYRAMIDAL SYMPTOM; FEMALE; FUNCTIONAL ASSESSMENT; HUMAN; HYPOTHESIS; MALE; MENTAL DISEASE; OUTPATIENT; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SCHIZOPHRENIA; TREATMENT OUTCOME;

ADULT; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; ANTIPSYCHOTIC AGENTS; DOUBLE-BLIND METHOD; DRUG SYNERGISM; FEMALE; HUMANS; MALE; MIDDLE AGED; NEUROPSYCHOLOGICAL TESTS; PLACEBOS; PSYCHIATRIC STATUS RATING SCALES; PYRAZOLES; SCHIZOPHRENIA; SULFONAMIDES; TIME FACTORS;

EID: 20444405296     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.biopsych.2005.02.024     Document Type: Article

References (15)

1. D. Addington, J. Addington, B. Schissel A depression rating scale for schizophrenics Schizophr Res 3 1990 247 251
2. N.C. Andreasen Negative symptoms in schizophrenia Arch Gen Psychiatry 39 1982 784 788
3. T.R. Barnes A rating scale for drug-induced akathisia Br J Psychiatry 154 1989 672 676
4. M.B. First, A. Frances, H.A. Pincus DSM-IV Handbook of Differential Diagnosis 1st ed 1995 American Psychiatric Press Washington, DC
5. W. Guy ECDEU Assessment Manual for Psychopharmacology 1976 U. S. Dept. of Health, Education, and Welfare, Public Health Service, Alcohol, Drug Abuse, and Mental Health Administration, National Institute of Mental Health, Psychopharmacology Research Branch, Division of Extramural Research Programs Rockville, Md
6. S.R. Kay, A. Fiszbein, L.A. Opler The positive and negative syndrome scale (PANSS) for schizophrenia Schizophr Bull 13 1987 261 276
7. M. Mirjany, L. Ho, G.M. Pasinetti Role of cyclooxygenase-2 in neuronal cell cycle activity and glutamate-mediated excitotoxicity J Pharmacol Exp Ther 301 2002 494 500
8. N. Müller, M. Riedel, C. Scheppach, B. Brandstatter, S. Sokullu, K. Krampe Beneficial antipsychotic effects of celecoxib add-on therapy compared to risperidone alone in schizophrenia Am J Psychiatry 159 2002 1029 1034
9. N. Müller, M. Ulmschneider, C. Scheppach, M.J. Schwarz, M. Ackenheil, H.J. Moller COX-2 inhibition as a treatment approach in schizophrenia immunological considerations and clinical effects of celecoxib add-on therapy Eur Arch Psychiatry Clin Neurosci 254 2004 14 22
10. M.H. Rapaport, J. Bazzetta, L.A. McAdams, T. Patterson, C.V. Jeste Validation of the Scale of Functioning in older outpatients with schizophrenia Am J Geriatr Psychiatry 4 1996 218 228
11. B.M. Ross, R.J. Brooks, M. Lee, K.S. Kalasinsky, S.P. Vorce, M. Seeman Cyclooxygenase inhibitor modulation of dopamine-related behaviours Eur J Pharmacol 450 2002 141 151
12. G.M. Simpson, J.W. Angus A rating scale for extrapyramidal side effects Acta Psychiatr Scand Suppl 212 1970 11 19
13. K.I. Strauss, A.M. Marini Cyclooxygenase-2 inhibition protects cultured cerebellar granule neurons from glutamate-mediated cell death J Neurotrauma 19 2002 627 638
14. L.B. Willard, B. Hauss-Wegrzyniak, W. Danysz, G.L. Wenk The cytotoxicity of chronic neuroinflammation upon basal forebrain cholinergic neurons of rats can be attenuated by glutamatergic antagonism or cyclooxygenase-2 inhibition Exp Brain Res 134 2000 58 65
15. O. Yokota, S. Terada, T. Ishihara, H. Nakashima, A. Kugo, H. Ujike Neuronal expression of cyclooxygenase-2, a pro-inflammatory protein, in the hippocampus of patients with schizophrenia Prog Neuropsychopharmacol Biol Psychiatry 28 2004 715 721